FDA INDICATION: Tretten® (coagulation factor XIII A-subunit [recombinant]) is indicated for routine prophylaxis of bleeding in patients with congenital factor XIII A-subunit deficiency. Package Insert
DISTRIBUTOR: Novo Nordisk
ROUTE OF ADMINISTRATION: Intravenous
ASSAY SIZE (IU): 2000–3125
DILUENT SIZE: 3.2 mL
MIXING DEVICE: Vial adapter
STORAGE: Store refrigerated at 2–8°C (36–46°F) prior to reconstitution. Tretten is stable until the expiration date on the carton and vial label. Do not freeze. Store protected from light.
HALF-LIFE: 5.1 (± 2.6) days